Pharmaceutical formulations of highly lipophilic camptothecin derivatives
US5880133A · kind A · utility
9Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 1996 |
| Grant date | Mar 9, 1999 |
| Priority date | — |
| Expiry date | Jun 21, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations of Highly Lipophilic Camptothecin Derivatives (HLCD) include HLCD dissolved in N-methyl Pyrrolidinene (NMP). The formulations also include quantities of pharmaceutically acceptable excipients and diluents incorporated thereinto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.